Guardian Pharmacy Services, Inc. (GRDN)
NYSE · Healthcare · Medical Care Facilities
$42.10−0.66%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $2.7B
- P/E (trailing)
- 40.9
- Forward P/E
- 29.4
- 52-week range
- $23.14 – $48.33
- 52-week change
- +78.52%
- EPS (trailing)
- $1.03
- Analyst rating
- 1.1 Strong buy
- Next earnings
- Nov 9, 2026
Fiscal year to Dec 2025
- Revenue
- $1.4B (+17.93%)
- Net income
- $49.2M
- Operating margin
- 5.0%
- Free cash flow
- $86.8M
From the company’s annual report on SEC EDGAR.
About Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
Headquarters: Atlanta, United States · 3,600 employees · guardianpharmacy.com